Wednesday, September 2, 2009

Advanced Cell Diagnostics Gets $5.4M

Hayward-based Advanced Cell Diagnostics (ACD), a developer of cell- and tissue-based diagnostic tests for personalized medicine, announced late Wednesday that the firm has completed a second close on a $5.4M, Series A funding. The financing came from Morningside Ventures. ACD said the funding will go to accelerate development of the firm's diagnostic tests. More information »